Application of Circulating Extracellular Vesicles in Early Disease Assessment and Prognosis After Traumatic Brain Injury
1 other identifier
observational
300
1 country
1
Brief Summary
The purpose of this study was to observe the relationship between the changes of circulating extracellular vesicles and disease development and outcome in patients with traumatic brain injury, and to find early serum markers and potential intervention targets for disease monitoring in patients with traumatic brain injury. In addition, explore the source of extracellular vesicles as much as possible to prepare for subsequent basic experiments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 25, 2022
CompletedFirst Submitted
Initial submission to the registry
January 26, 2022
CompletedFirst Posted
Study publicly available on registry
March 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedMarch 31, 2022
March 1, 2022
9 months
January 26, 2022
March 15, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The type and content of circulating extracellular vesicles
After isolation of circulating extracellular vesicles, RNA sequencing was performed to determine noncoding RNA changes in circulating extracellular vesicles. Screening criteria were based on logFC and P value, generally with \|logFC\|\>2 and AP value \<0.05 to define whether there was a difference.
within 24 hours of TBI
Neurological deterioration in patients with traumatic brain injury
Neurological deterioration (ND) was defined as the occurrence of one or more of the following criteria within 7 days after injury: (a) a decrease in GCS score of 2 points or more from the initial GCS score with no pharmacological sedation; (b) a deterioration in neurological status being sufficient to neurosurgical intervention.
within 7 days after injury
Secondary Outcomes (2)
hospital stay
From hospitalization to discharge,up to one month
GOSE score
three months or six months
Eligibility Criteria
All TBI patients treated at Tangdu Hospital from January 2022 to December 2022
You may qualify if:
- No systematic treatment before admission;
- The patient is diagnosed with traumatic brain injury with imaging evidence;
- Age \> 18 years old;
- The patient or family members agree to sign the informed consent.
You may not qualify if:
- Infectious diseases within the past 1 month;
- Past head trauma, history of neurological diseases;
- Non-isolated traumatic brain injury;
- The patient is not receiving treatment in this hospital;
- Severe disability, dementia, or organ dysfunction before the onset of the disease;
- Subject refuses to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tang-Du Hospitallead
Study Sites (1)
Tandu Hospital, Fourth Military Medical University
Xi'an, China
Biospecimen
1. Peripheral blood was collected in a negative pressure vacuum tube and transferred to the refrigerator -80 for storage as soon as possible. 2. Peripheral blood-related cells are subsequently collected or cultured to observe the relationship between related molecules and circulating extracellular vesicles.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yan Qu, M.D, Ph.D
Tang-Du Hospital
- PRINCIPAL INVESTIGATOR
Qing Hu, M.D
Tang-Du Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2022
First Posted
March 15, 2022
Study Start
January 25, 2022
Primary Completion
November 1, 2022
Study Completion
November 1, 2022
Last Updated
March 31, 2022
Record last verified: 2022-03